Alexandra Leary, MD, PhD, Gustave Roussy Institute, Villejuif, France, highlights the importance of understanding the molecular subtypes of endometrial cancer, and touches on its prognostic value, its role in adjuvant treatment, as well as the potential to guide targeted therapies. This interview took place at the European Society of Gynaecological Oncology (ESGO) 2021 congress in Prague.